A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy
一项针对接受初始免疫检查点抑制剂治疗后进展的转移性尿路上皮癌患者的Guadecitabine联合Atezolizumab II期临床试验
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-22-3642
Jang, H Josh; Hostetter, Galen; Macfarlane, Alexander W; Madaj, Zachary; Ross, Eric A; Hinoue, Toshinori; Kulchycki, Justin R; Burgos, Ryan S; Tafseer, Mahvish; Alpaugh, R Katherine; Schwebel, Candice L; Kokate, Rutika; Geynisman, Daniel M; Zibelman, Matthew R; Ghatalia, Pooja; Nichols, Peter W; Chung, Woonbok; Madzo, Jozef; Hahn, Noah M; Quinn, David I; Issa, Jean-Pierre J; Topper, Michael J; Baylin, Stephen B; Shen, Hui; Campbell, Kerry S; Jones, Peter A; Plimack, Elizabeth R